Glooko, Inc., an enterprise software partner for diabetes and glycemic management from hospital to home, today announced its selection as a finalist in the Best in Class track for Cardiometabolic, Obesity & Diabetes in the Digital Health Hub Foundation Digital Health & AI Awards 2026 at HLTH.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027110711/en/

The awards honor organizations using digital innovation to improve healthcare delivery, efficiency and equity. The recognition highlights Glooko’s commitment to improving the lives of people with diabetes and supporting the clinical and research communities that serve them.

“Health is most easily attained and best achieved when you strengthen the therapeutic alliance between clinicians and people with diabetes,” said Mark Clements, M.D., Ph.D., Chief Medical and Strategy Officer at Glooko. “That belief guides our work at Glooko: helping care teams and people with diabetes use shared information to make more informed decisions and stay connected between visits. Being a finalist recognizes the progress our team has made alongside the diabetes community, clinicians and partners to support better care from hospital to home.”

Glooko’s portfolio brings specialized capabilities to the settings where diabetes and glycemic care happen. Glooko EndoTool supports clinicians with patient-specific decision support for inpatient insulin dosing, while GlookoCare supports outpatient diabetes management through device-neutral data review and EHR-connected workflows. Its new GestationalCare module addresses the distinct needs of diabetes in pregnancy, and the GlookoConnect App helps people with diabetes share data and daily context with their community and care teams.

Glooko also supports the broader diabetes ecosystem through device and technology partnerships, real-world data and clinical-trial capabilities that help life sciences organizations advance research and innovation.

Across all tracks and categories, this year’s finalists were selected from more than 1,300 submissions.

“The transition from quarterfinalist to finalist is where the competition really gets exciting,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation. “We’re seeing companies move beyond promising ideas to solutions that are changing how healthcare is delivered, experienced, and accessed. Our finalists represent an extraordinary range of innovation, and we can’t wait to bring their achievements to the stage at HLTH in November.”

The 2026 Digital Health & AI Awards will culminate on Monday, November 16, at HLTH USA at The Venetian in Las Vegas, where winners will be revealed live during three themed awards shows at the Awards Pavilion.

Awards Day at HLTH

Monday, November 16, 2026

  • 1:00 PM — Healthcare for Everyone: Access, Care & Community

    Recognizing innovation in civic health, caregiving and aging, oral health, and cardiometabolic care.

  • 2:30 PM — The Future of Medicine

    Celebrating advancements in cancer detection, therapeutics and pharmacy, and women’s and family health.

  • 5:00 PM — The Future of Health & Intelligent Care

    Highlighting transformative care delivery, home and remote care, mental and brain health, and healthy lifespan and longevity.

About Digital Health Hub Foundation

The Digital Health Hub Foundation’s mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017 on the campus of UCSF in San Francisco, its 30,000-member community consists of thousands of early- to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers. Its annual awards ceremony brings the industry together to honor and validate the best of the best and celebrate technological advances in healthcare and their impact.

About Glooko

Glooko, Inc. is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. Glooko is uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.

For more information, visit glooko.com.

Media gallery

About The Author
Business Wire